Hypopigmentary effects of 4-n-butylresorcinol and resveratrol in combination

Pharmazie

Volumn 67, Issue 6, 2012, Pages 542-546

  Kim, Su Yeon ^a   Park, Kyoung Chan ^b   Kwon, Sun Bang ^c   Kim, Dong Seok ^a  

^a Chung Ang University College of Medicine   (South Korea)

^b Seoul National University College of Medicine   (South Korea)

^c Welskin Co Ltd   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

4 N BUTYLRESORCINOL; MELANIN; MONOPHENOL MONOOXYGENASE; RESORCINOL DERIVATIVE; RESVERATROL; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DRUG EFFECT; DRUG POTENTIATION; ENZYME INHIBITION; HYPOPIGMENTATION; MELANOGENESIS; MOUSE; NONHUMAN; PROTEIN EXPRESSION; TRANSCRIPTION REGULATION; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; CELL LINE; CELL SURVIVAL; DRUG COMBINATIONS; DRUG SYNERGISM; ENZYME INHIBITORS; MELANINS; MELANOCYTES; MICE; MICROSCOPY, PHASE-CONTRAST; MONOPHENOL MONOOXYGENASE; RESORCINOLS; SKIN; SKIN PIGMENTATION; STILBENES;

EID: 84862540722     PISSN: 00317144     EISSN: None     Source Type: Journal    
DOI: 10.1691/ph.2012.1660     Document Type: Article

References (19)

1. Bentley NJ, Eisen T, Goding CR (1994) Melanocyte-specific expression of the human tyrosinase promoter: activation by the microphthalmia gene product and role of the initiator. Mol Cell Biol 14: 7996-8006.
2. Bertolotto C, Busca R, Abbe P, Bille K, Aberdam E, Ortonne JP, Ballotti R (1998) Different cis-acting elements are involved in the regulation of TRP1 and TRP2 promoter activities by cyclic AMP: pivotal role of M boxes (GTCATGTGCT) and of microphthalmia. Mol Cell Biol 18: 694-702.
3. Chen QX, Ke LN, Song KK, Huang H, Liu XD (2004) Inhibitory effects of hexylresorcinol and dodecylresorcinol on mushroom (Agaricus bisporus) tyrosinase. Protein J 23: 135-141.
4. Dooley TP, Gadwood RC, Kilgore K, Thomasco LM (1994) Development of an in vitro primary screen for skin depigmentation and antimelanoma agents. Skin Pharmacol 7: 188-200.
5. Ha YM, Chung SW, Song S, Lee H, Suh H, Chung HY (2007) 4-(6-Hydroxy-2-naphthyl)-1,3-bezendiol: a potent, new tyrosinase inhibitor. Biol Pharm Bull 30: 1711-1715.
6. Hearing VJ, Jimenez M (1989) Analysis of mammalian pigmentation at the molecular level. Pigment Cell Res 2: 75-85.
7. Hearing VJ, Tsukamoto K (1991) Enzymatic control of pigmentation in mammals. Faseb J 5: 2902-2909.
8. Kairisalo M, Bonomo A, Hyrskyluoto A, Mudo G, Belluardo N, Korhonen L, Lindholm D (2011) Resveratrol reduces oxidative stress and cell death and increases mitochondrial antioxidants and XIAP in PC6.3-cells. Neurosci Lett 488: 263-266.
9. Khemis A, Kaiafa A, Queille-Roussel C, Duteil L, Ortonne JP (2007) Evaluation of efficacy and safety of rucinol serum in patients with melasma: a randomized controlled trial. Br J Dermatol 156: 997-1004.
10. Kim DS, Kim SY, Park SH, Choi YG, Kwon SB, Kim MK, Na JI, Youn SW, Park KC (2005) Inhibitory effects of 4-n-butylresorcinol on tyrosinase activity and melanin synthesis. Biol Pharm Bull 28: 2216-2219.
11. Kim DS, Lee S, Lee HK, Park SH, Ryoo IJ, Yoo ID, Kwon SB, Baek KJ, Na JI, Park KC (2008) The hypopigmentary action of KI-063 (a new tyrosinase inhibitor) combined with terrein. J Pharm Pharmacol 60: 343-348.
12. Kim YM, Yun J, Lee CK, Lee H, Min KR, Kim Y (2002) Oxyresveratrol and hydroxystilbene compounds. Inhibitory effect on tyrosinase and mechanism of action. J Biol Chem 277: 16340-16344.
13. Kobayashi T, Urabe K, Winder A, Jimenez-Cervantes C, Imokawa G, Brewington T, Solano F, Garciaborron JC, Hearing VJ (1994) Tyrosinase related protein 1 (TRP1) functions as a DHICA oxidase in melanin biosynthesis. Embo J 13: 5818-5825.
14. Lin CB, Babiarz L, Liebel F, Roydon Price E, Kizoulis M, Gendimenico GJ, Fisher DE, Seiberg M (2002) Modulation of microphthalmia-associated transcription factor gene expression alters skin pigmentation. J Invest Dermatol 119: 1330-1340.
15. Newton RA, Cook AL, Roberts DW, Leonard JH, Sturm RA (2007) Posttranscriptional regulation of melanin biosynthetic enzymes by cAMP and resveratrol in human melanocytes. J Invest Dermatol 127: 2216-2227.
16. Shimizu K, Kondo R, Sakai K (2000) Inhibition of tyrosinase by flavonoids, stilbenes and related 4-substituted resorcinols: structure-activity investigations. Planta Med 66: 11-15.
17. Tasaka K, Kamei C, Nakano S, Takeuchi Y, Yamato M (1998) Effects of certain resorcinol derivatives on the tyrosinase activity and the growth of melanoma cells. Methods Find Exp Clin Pharmacol 20: 99-109.
18. Tsuboi T, Kondoh H, Hiratsuka J, Mishima Y (1998) Enhanced melanogenesis induced by tyrosinase gene-transfer increases boron-uptake and killing effect of boron neutron capture therapy for amelanotic melanoma. Pigment Cell Res 11: 275-282.
19. Yokoyama K, Suzuki H, Yasumoto K, Tomita Y, Shibahara S (1994) Molecular cloning and functional analysis of a cDNA coding for human DOPAchrome tautomerase/tyrosinase-related protein-2. Biochim Biophys Acta 1217: 317-321.